Contact Us

Focus

CARsgen's Allogeneic CD38 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial

SHANGHAI,Jan. 20,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors

Focus

Jan 21, 2025

DAHON Unveils Groundbreaking D-VELO Speed Technology at CABDA 2025 in New York

NEW YORK,Jan. 21,2025-- On January 15,theCABDA EAST Expo kicked off at the Meadowlands Exposition Center in New York,where DAHON unveiled its new "D-VELO" technology,captivating the interest

Focus

Jan 21, 2025

Budget Direct Insurance Launches Commercial Vehicle Insurance in Singapore

SINGAPORE,Jan. 21,2025--Budget Direct Insurance,a leading direct-to-consumer digital insurer,has announced the launch of its Commercial Vehicle Insurance product,designed to meet the needs of business

Focus

Jan 21, 2025

YolTech Therapeutics to Initiate a Clinical Trial for YOLT-204, a First-in-Class Bone Marrow-Targeted In Vivo Gene Editing Therapy for β-Thalassemia

SHANGHAI,Jan. 21,2025--YolTech Therapeutics,a clinical-stage gene editing company dedicated to delivering lifelong cures,announced the initiation of a clinical trial for YOLT-204,an investigational th

Focus

Jan 21, 2025

Ascentium Expands Strategic Footprint in the Middle East through Acquisition of Virtuzone

SINGAPORE,Jan. 21,2025-- Ascentium,a leading global business services platform headquartered in Singapore and backed by Hillhouse Investment,has announced the acquisition of Virtuzone,the UAE\'s lead

Focus

Jan 21, 2025

Legendary PC Online Multi-Player Game Gunbound Returns with Closed Beta for Southeast Asia and Latin America.

SINGAPORE,Jan. 16,2025-- Gravity Game Hub (GGH) PTE. LTD.,a subsidiary of GRAVITY Co.,Ltd. (NasdaqGM: GRVY) is making a major comeback with the Closed Beta Test (CBT) for the legendary artillery game,

Focus

Jan 20, 2025
1 ... 113 114 115 116 117 118 119 ... 130